Articles liés à Transdermal Drug Delivery System: To deliver drugs...

Transdermal Drug Delivery System: To deliver drugs into systemic circulation through skin - Couverture souple

Debnath, Sudip; Saha, Ashoke

 
9783659163821: Transdermal Drug Delivery System: To deliver drugs into systemic circulation through skin
Couverture souple
ISBN 10 : 3659163821 ISBN 13 : 9783659163821
Editeur : LAP LAMBERT Academic Publishing, 2012

Synopsis

During the past few years, interest in the development of novel drug delivery systems for existing drug molecules has been renewed. The development of a novel delivery system for existing drug molecules not only improves the drug's performance in terms of efficacy and safety but also improves patient compliance and overall therapeutic benefit to a significant extent. Transdermally delivered drugs avoid the risk and inconvenience of intravenous therapy, usually provide less chance of an overdose or underdose, allow easy termination, and permit both local and systemic treatment effects. Transdermal drug delivery offers controlled release of the drug into the patient, it enables a steady blood level profile, resulting in reduced systemic side effects and, sometimes, improved efficacy over other dosage forms. The main objective of transdermal drug delivery system is to deliver drugs into systemic circulation through skin at predetermined rate with minimal inter and intra patient variation. The growth rate for transdermal drug delivery systems is expected to increase 12% annually by 2007.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

During the past few years, interest in the development of novel drug delivery systems for existing drug molecules has been renewed. The development of a novel delivery system for existing drug molecules not only improves the drug's performance in terms of efficacy and safety but also improves patient compliance and overall therapeutic benefit to a significant extent. Transdermally delivered drugs avoid the risk and inconvenience of intravenous therapy, usually provide less chance of an overdose or underdose, allow easy termination, and permit both local and systemic treatment effects. Transdermal drug delivery offers controlled release of the drug into the patient, it enables a steady blood level profile, resulting in reduced systemic side effects and, sometimes, improved efficacy over other dosage forms. The main objective of transdermal drug delivery system is to deliver drugs into systemic circulation through skin at predetermined rate with minimal inter and intra patient variation. The growth rate for transdermal drug delivery systems is expected to increase 12% annually by 2007.

Biographie de l'auteur

Sudip Debnath is currently pursuing MSc in Medical Cell Biology at University of Bergen, Norway. Prior to that he did his BSc and MS from Biochemistry and Molecular Biology, University of Dhaka. He had more than three years of professional experience in Eskayef Bangladesh Limited. Besides academic activities, Debnath is closely involved to research

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2012
Langue
anglais
ISBN 10 
3659163821
ISBN 13 
9783659163821
Reliure
Broché
Nombre de pages
56
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne